Survey says new CMS rule may force hospital cardiac implant cutbacks; J&J hip implant lawsuit settled out of court;

 @FierceMedDev: Looks like the U.S. endoscopy device market will double over the next six years. Release | Follow @FierceMedDev

 @MarkHFierce: A CMS coverage decision could reduce the amount of cardiac implants hospitals perform each year, says a new survey. More | Follow @MarkHFierce

 @DamianFierce: Developers look for FDA approval for medical device-like apps. Article | Follow @DamianFierce

> Nearly 75% of hospital CFOs polled in a recent survey said their facilities would likely cut back the number of pacemaker, defibrillator and other electronic cardiac device implants in the face of a new Centers for Medicare and Medicaid Services rule affecting reimbursement, assuming they can offer alternative treatment options. Release

> The first lawsuit over Johnson & Johnson ($JNJ) unit DuPuy's ASR hip implant has been settled out of court, but the devicemaker still faces a bevy of similar suits around the world. Article

> Forbes takes a closer look at the controversy surrounding the FDA's surveillance of its own employees, reporting that the targeted scientists may have had a financial interest in leaking agency documents. Story

> InSightec got the FDA's blessing to start a Phase I trial evaluating the use of its ExAblate Neuro device in treating Parkinson's disease. Item

> Smiths Medical signed a deal with Nexus Medical to distribute the company's Nexus TKO anti-reflux needle free valves and extension sets. News

> LabCorp ($LH) wants to sell senior notes that will help fund general operations but also repay existing debt dating back to Dec. 21, 2011. Release

> Rosetta Genomics is predicting big growth in its microRNA diagnostic assays, and, to prepare, the company has expanded its executive leadership and lab capacity. Release

Biotech News

 @FierceBiotech: Check out's 10 Big Pharma smartphone apps slideshow. Special Feature | Follow @FierceBiotech

 @JohnCFierce: J&J forking over another $50M milestone to Pharmacyclics for their btk partnership. Now that's how you reap biobucks. Release | Follow @JohnCFierce

 @RyanMFierce: DNA data-crunching contest draws Sanofi, NIH, others. Report | Follow @RyanMFierce

> Booming Pharmacyclics snags $50M paycheck as J&J pact drives blood cancer trials. More

> FDA calendar crowded with blockbuster decisions for Ironwood, Pfizer and Sanofi. News

> New lab organs promise faster, cheaper, better drug development. Report

> Regulus Therapeutics files for $58M IPO. Story

Pharma News

 @FiercePharma: China significantly ratchets back drugs on 'essential drugs' list. More | Follow @FiercePharma

> FDA has four big drug decisions lined up. Item

> Predictions for emerging markets hit new realities. Story

> Company convicted in gray market distribution scheme. Article

CRO News

> Report: 211 died in Indian trials in first half of 2012. More

> Icon banks on translational medicine with U.K. expansion. Item

> CROs: Go green to woo Pfizer. More

> INC picks three of its own for new C-level spots. Report

> Report: Indian CRO market will double, reach $1B in 2016. Story

Biotech IT News

> DNA data-crunching contest draws Sanofi, NIH, others. Story

> Lilly's 'big data' ally finds new Indy digs for IT workers. More

> Big data analytics bolsters hunt for elusive Huntington's drugs. Article

> Quintiles gains genomic, bioinformatics know-how in buyout. Item